Botox 100 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FQWG2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,660
Award facts
- Contract value 100% obligated
- $22,660.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $22,660.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of BOTOX 100 Unit Vials. The award was issued on December 15, 2025, with an ultimate completion date of January 7, 2026, under a firm fixed-price contract structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded in November 2025 with a $499.999 billion ceiling value extending through December 31, 2036.
The PPV-G GEN V represents part of the Defense Logistics Agency's broader $30.3 billion acquisition strategy to establish regional pharmaceutical prime vendor contractors supporting the Department of Defense's worldwide military healthcare operations. DMS Pharmaceutical Group's role as a prime contractor under this initiative demonstrates its capability to supply a comprehensive range of pharmaceutical products, including branded and generic medications, biologics, vaccines, and specialty pharmaceuticals to federal military medical facilities. The company's established performance across numerous delivery orders reflects its position as a critical supplier within the Defense Logistics Agency's pharmaceutical supply chain for military healthcare requirements.
Quick answers
Who was awarded contract SPE2DR26FQWG2?
SPE2DR26FQWG2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26FQWG2 worth?
The government has obligated $22,660 on SPE2DR26FQWG2.
Is contract SPE2DR26FQWG2 an order under another contract?
Yes. SPE2DR26FQWG2 is a delivery order under SPE2DR25D9353, an indefinite delivery contract.
Was contract SPE2DR26FQWG2 competed?
The extent of competition for SPE2DR26FQWG2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award